Vimian Group AB (publ) (OTCMKTS:VIMGF – Get Free Report) shot up 7.3% on Friday . The company traded as high as C$3.89 and last traded at C$3.89. 26,000 shares traded hands during mid-day trading, an increase of 87% from the average session volume of 13,867 shares. The stock had previously closed at C$3.62.
Vimian Group AB (publ) Price Performance
The company has a 50-day moving average price of C$3.63 and a 200-day moving average price of C$3.43.
About Vimian Group AB (publ)
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.
Featured Articles
- Five stocks we like better than Vimian Group AB (publ)
- The Significance of Brokerage Rankings in Stock Selection
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- Trading Halts Explained
- These 3 Quirky ETFs May Be Strong Plays in 2025
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
Receive News & Ratings for Vimian Group AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vimian Group AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
